Tuesday, June 2, 2009

Celergen Clinical Studies

After intensive research, CELERGEN Swiss, French and German scientists have discovered the powerful anti-aging properties of Bio DNA Cellular marine complex. It is produced from premium quality marine life by celergens exclusively patented proprietary biological DNA extraction technology.

This method avoids the depolymerization of DNA thereby guarantee maximum activity (as standard DNA which is non-polymerized if taken regularly, may have adverse effect on one’s health by increasing blood level of uric acid) and is naturally hydrosoluble and it is perfectly compatible, after ingestion it is almost completely absorbed by the body.


BIO DNA cellular marine complex, has anti-oxidating properties. As a natural free Radical Scavenger, it gives protection against oxidative stress in cells, terminates the process of peroxydation by avoiding the formation of a new free radical. Free Radical are very reactive chemicals formed in small molecules during normal metabolism. Their accumulation induces cell damage and accelerate skin aging. BIO DNA Cellular marine complex has the following capabilities:

- a regenerative action for post traumatic wounds such as gastric ulcers.
An experiment was done on rat, one hour after the administration of 325 mg/kg of aspirin, the taking of BIO DNA Cellular marine complex (10-50 mg/kg) prevented the apparition of gastric ulcers from aspirin.

- possesses a radiation protective power.

- the protection power is directly proportional to the degree of polymerization (as in ours which is highly polymerized BIO DNA Cellular marine complex).
An experiment was done on rats with mortal doses of radiation were found to survive or tolerated the undesirable effects of radiation therapy, when Bio DNA cellular marine complex were given prior to radiation.

- has immunostimulating activities.

- improves physical and mental performance.

- improves stamina during exercises and improves recuperation after exercise.

Below are some results of independent clinical studies of Celergen.




No comments: